Century Therapeutics, Inc.
US ˙ NasdaqCM ˙ US15673T1007

SecurityIPSC / Century Therapeutics, Inc.
InsiderDouglas Carr
This page shows the track record and history of Carr Douglas insider trades in Century Therapeutics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Douglas Carr in IPSC / Century Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IPSC / Century Therapeutics, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Douglas Carr in IPSC / Century Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-09-08 263 0.5000 263 0.5000 132 11 0.4772 -5 -4.20
2025-08-04 296 0.5340 296 0.5340 158
2025-06-09 4,904 0.6220 4,904 0.6220 3,050
2025-05-05 295 0.5500 295 0.5500 162
2025-03-10 1,240 0.6150 1,240 0.6150 763
2025-02-03 351 0.7800 351 0.7800 274
2024-11-04 283 1.2270 283 1.2270 347
2024-08-05 289 1.8270 289 1.8270 528
2024-05-03 257 3.1060 257 3.1060 798
2024-02-06 557 4.4870 557 4.4870 2,499
2024-02-05 643 3.8410 643 3.8410 2,470

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IPSC / Century Therapeutics, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-10 2025-09-08 4 Carr Douglas IPSC Common Stock S - Sale D 0.5000 -263 -0 405,423
2025-08-06 2025-08-04 4 Carr Douglas IPSC Common Stock S - Sale D 0.5340 -296 -0 405,686
2025-06-11 2025-06-09 4 Carr Douglas IPSC Common Stock S - Sale D 0.6220 -4,904 -3 405,982
2025-05-07 2025-05-05 4 Carr Douglas IPSC Common Stock S - Sale D 0.5500 -295 -0 410,886
2025-03-12 2025-03-11 4 Carr Douglas IPSC Common Stock A - Award D 95,625 411,181
2025-03-12 2025-03-10 4 Carr Douglas IPSC Common Stock S - Sale D 0.6150 -1,240 -1 315,556
2025-02-05 2025-02-03 4 Carr Douglas IPSC Common Stock S - Sale D 0.7800 -351 -0 316,796
2024-11-05 2024-11-04 4 Carr Douglas IPSC Common Stock S - Sale D 1.2270 -283 -0 317,147
2024-11-05 2024-11-01 4 Carr Douglas IPSC Common Stock F - Taxes D 1.2600 -16,611 -21 317,430
2024-08-07 2024-08-05 4 Carr Douglas IPSC Common Stock S - Sale D 1.8270 -289 -1 334,041
2024-06-10 2024-06-07 4 Carr Douglas IPSC Common Stock A - Award D 17,007 334,330
2024-05-07 2024-05-03 4 Carr Douglas IPSC Common Stock S - Sale D 3.1060 -257 -1 317,323
2024-03-11 2024-03-07 4 Carr Douglas IPSC Common Stock A - Award D 14,000 317,580
2024-02-07 2024-02-06 4 Carr Douglas IPSC Common Stock S - Sale D 4.4870 -557 -2 303,580
2024-02-07 2024-02-05 4 Carr Douglas IPSC Common Stock S - Sale D 3.8410 -643 -2 304,137
2023-11-03 2023-11-01 4 Carr Douglas IPSC Common Stock F - Taxes D 1.4900 -16,611 -25 304,780
2023-05-17 2023-05-15 4 Carr Douglas IPSC Common Stock A - Award D 120,846 321,391
2023-02-06 2023-02-02 4 Carr Douglas IPSC Common Stock A - Award D 7,500 200,545
2023-02-06 2023-02-02 4 Carr Douglas IPSC Common Stock A - Award D 7,500 200,545
2022-01-27 2022-01-25 4 Carr Douglas IPSC Stock Option (right to buy) A - Award D 13.15 35,000 35,000
2021-06-17 3 Carr Douglas IPSC Common Stock D 203,430
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)